Literature DB >> 21111455

Oncocytic carcinoma of the breast: frequency, morphology and follow-up.

Moira Ragazzi1, Dario de Biase, Christine M Betts, Anna Farnedi, Saime Sezgin Ramadan, Giovanni Tallini, Jorge S Reis-Filho, Vincenzo Eusebi.   

Abstract

Oncocytic breast carcinomas are tumors composed of no fewer than 70% of oncocytic cells (World Health Organization). The purpose of this study was to determine the frequency, morphologic, immunohistochemical, and clinical features of invasive oncocytic carcinoma in a large series. Twenty-eight cases of putative oncocytic breast carcinoma (selected cases group) and 76 consecutive cases of invasive breast carcinoma (consecutive cases group) were analyzed. Immunohistochemistry for mitochondria, gross cystic disease fluid protein 15, chromogranin, estrogen receptor, progesterone receptor, androgen receptor, HER2/Neu, cytokeratin 7, cytokeratin 14, epithelial membrane antigen, and differentiation cluster 68 was performed. Score for mitochondria was based on intensity and percentage of immunopositive cells. Classes were as follows: (1) oncocytic carcinoma: at least 70%, 3+; (2) mitochondrion-rich carcinoma: 50% to 70%, 3+, or more than 50%, 2+; and (3) all the other cases were referred to as invasive breast carcinoma. Ultrastructural examination was available for 6 cases of oncocytic carcinoma. Morphologic and immunohistochemical features of the 3 groups were compared using Fisher exact test (P < .05). For overall survival analysis, Kaplan-Maier curves were compared using log-rank and Wilcoxon tests (P < .05). Our results suggest that oncocytic breast carcinoma is a morphologic entity with distinctive histologic and ultrastructural features. Mitochondrion-rich carcinomas are histologically similar to oncocytic carcinomas and constitute 19.7% of all invasive carcinomas, indicating that cytoplasmic eosinophilia in breast cancer cells is often due to accumulation of mitochondria. Oncocytic carcinomas and mitochondrion-rich carcinomas are more often grade III tumors and show human epidermal growth factor receptor 2 overexpression. Clinical features and overall survival of oncocytic carcinomas are not distinctive because they are similar to those of the other cases when matched for grade and stage. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111455     DOI: 10.1016/j.humpath.2010.07.014

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.

Authors:  Asterios Triantafyllou; Jennifer L Hunt; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-07       Impact factor: 2.503

2.  Synchronous and bilateral oncocytic carcinoma of the breast: A case report and review of the literature.

Authors:  Hiroko Itagaki; Tomoko Yamamoto; Atsuko Hiroi; Kunio Kawanishi; Eiichiro Noguchi; Tetsuya Ohchi; Takako Kamio; Shingo Kameoka; Hideaki Oda; Yoji Nagashima
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

Review 3.  Apocrine lesions of the breast.

Authors:  Cecily M Quinn; Clare D'Arcy; Clive Wells
Journal:  Virchows Arch       Date:  2021-09-18       Impact factor: 4.535

4.  Male breast cancer-review of literature on a rare microscopic variant (oncocytic carcinoma).

Authors:  Nisha Jayashankar Marla; Muktha Ramesh Pai; Gumballi Krishnamurthy Swethadri; Hilda Fernandes
Journal:  Indian J Surg       Date:  2012-07-05       Impact factor: 0.656

Review 5.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

6.  Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasis.

Authors:  T C Kenny; P Hart; M Ragazzi; M Sersinghe; J Chipuk; M A K Sagar; K W Eliceiri; T LaFramboise; S Grandhi; J Santos; A K Riar; L Papa; M D'Aurello; G Manfredi; M G Bonini; D Germain
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 7.  Histology of Luminal Breast Cancer.

Authors:  Ramona Erber; Arndt Hartmann
Journal:  Breast Care (Basel)       Date:  2020-07-15       Impact factor: 2.860

8.  High mitochondria content is associated with prostate cancer disease progression.

Authors:  Katharina Grupp; Karolina Jedrzejewska; Maria Christina Tsourlakis; Christina Koop; Waldemar Wilczak; Meike Adam; Alexander Quaas; Guido Sauter; Ronald Simon; Jakob Robert Izbicki; Markus Graefen; Hartwig Huland; Thorsten Schlomm; Sarah Minner; Stefan Steurer
Journal:  Mol Cancer       Date:  2013-11-21       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.